Metraipolis › archive › dc_4bcfe8986b67
Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study — Europe PMC PMID:42519797
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42519797
- DOI
- 10.3389/fmed.2026.1866311
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T11:04:40.618Z
- SHA-256 of the archived text
7374427ba582cef2c04ae0cc5cfc866ba4637e0b7f49ad2b00b9fd1ae53432cf- Stable URL of this page
https://metraipolis.com/documento/dc_4bcfe8986b67
How to cite
Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study — Europe PMC PMID:42519797 — Europe PMC (en), https://europepmc.org/article/MED/42519797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bcfe8986b67 (Metraipolis archive dc_4bcfe8986b67, sha256 7374427ba582cef2c04ae0cc5cfc866ba4637e0b7f49ad2b00b9fd1ae53432cf)
BibTeX
@misc{dc4bcfe8986b67,
title = {Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study — Europe PMC PMID:42519797},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42519797},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bcfe8986b67; sha256 7374427ba582cef2c04ae0cc5cfc866ba4637e0b7f49ad2b00b9fd1ae53432cf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42519797. Agents can read the archived copy with the MCP tool read_document.